1. Home
  2. NMRA vs NWS Comparison

NMRA vs NWS Comparison

Compare NMRA & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

424.4M

Sector

N/A

ML Signal

HOLD

Logo News Corporation Class B

NWS

News Corporation Class B

HOLD

Current Price

$25.97

Market Cap

17.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMRA
NWS
Founded
2019
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
424.4M
17.0B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
NMRA
NWS
Price
$3.16
$25.97
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$8.00
$37.94
AVG Volume (30 Days)
1.7M
1.6M
Earning Date
03-02-2026
02-05-2026
Dividend Yield
N/A
0.78%
EPS Growth
N/A
178.51
EPS
N/A
2.02
Revenue
N/A
$8,624,000,000.00
Revenue This Year
N/A
$5.12
Revenue Next Year
N/A
$3.39
P/E Ratio
N/A
$12.67
Revenue Growth
N/A
2.42
52 Week Low
$0.61
$25.51
52 Week High
$3.47
$35.58

Technical Indicators

Market Signals
Indicator
NMRA
NWS
Relative Strength Index (RSI) 80.32 28.05
Support Level $1.91 $25.51
Resistance Level $3.47 $27.41
Average True Range (ATR) 0.23 0.92
MACD 0.14 -0.45
Stochastic Oscillator 87.78 1.36

Price Performance

Historical Comparison
NMRA
NWS

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About NWS News Corporation Class B

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

Share on Social Networks: